Tags : ~$24M

Aytu BioScience to Acquire Innovus Pharmaceuticals for ~$24M

Tuba Khan September 13, 2019

Shots: Aytu acquires Innovus in cash & stock transaction making a total deal value up to $24M. Innovus to receive up to $8M shares in Aytu’s common stock as upfront […]readmore

Tags : ~$24M

Aytu BioScience to Acquire Innovus Pharmaceuticals for ~$24M

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : ~$24M

﻿Aytu BioScience to Acquire Innovus Pharmaceuticals for ~$24M

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company

Aytu BioScience to Acquire Innovus Pharmaceuticals for ~$24M